Literature DB >> 9690210

Immunocytochemical detection of advanced glycated end products in rat renal tissue as a function of age and diabetes.

M Bendayan1.   

Abstract

BACKGROUND: High blood glucose levels play major roles in the pathogenesis of renal diabetic complications through non-enzymatic glycation. For long-lived molecules this leads to formation of advanced glycation end products (AGE), and the renal extracellular matrix appears to be one of the targets for such processes. Using immunocytochemistry, we studied the appearance and deposition of AGE products in renal tissues from normal and diabetic rats at different ages, to evaluate the effects of aging and hyperglycemia.
METHODS: The streptozotocin-injected rat represented our model of hyperglycaemic condition. The immunogold techniques were applied at the light and electron microscope levels using specific monoclonal and polyclonal antibodies against AGE adducts. The results were analyzed by morphometry.
RESULTS: In normoglycemic animals, significant increases in labeling were detected in tubular basement membranes and mesangial matrix at 12 to 15 months of age. In contrast, in diabetic animals, significant increases in labeling were found for all extracellular matrices as soon as after two months of hyperglycemia. Labelings were also detected in cellular compartments, particularly in nuclei that showed increases in diabetic conditions. The labeling was particularly intense in proximal convoluted tubules and their endosomal compartment, due to the reabsorption of urinary AGE products.
CONCLUSION: The presence of AGE products in the renal extracellular matrix of old normoglycemic animals and their rapid appearance in hyperglycemia, indicate that AGE products may participate in the pathogenesis of renal complications. Furthermore, the non-enzymatic glycation is not restricted to extracellular matrices but also affects cellular proteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690210     DOI: 10.1046/j.1523-1755.1998.00030.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

Review 1.  The aging kidney: a review -- part I.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 2.  New potential agents in treating diabetic kidney disease: the fourth act.

Authors:  Mark E Williams
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats.

Authors:  J L Figarola; S Scott; S Loera; C Tessler; P Chu; L Weiss; J Hardy; S Rahbar
Journal:  Diabetologia       Date:  2003-07-05       Impact factor: 10.122

4.  Glomerular CD34 expression in short- and long-term diabetes.

Authors:  Luz Marina Acevedo; Irene Londono; Malika Oubaha; Lucian Ghitescu; Moise Bendayan
Journal:  J Histochem Cytochem       Date:  2008-03-03       Impact factor: 2.479

5.  Type 2 diabetes progression differently affects endothelial function and vascular contractility in the aorta and the pulmonary artery.

Authors:  Bernardete F Melo; Jesus Prieto-Lloret; Marlene D Cabral; Fatima O Martins; Inês B Martins; Joana F Sacramento; Pedro Ruivo; Tânia Carvalho; Silvia V Conde
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379

6.  Advanced glycation end products in human diabetic lens capsules.

Authors:  Johanna Rankenberg; Stefan Rakete; Brandie D Wagner; Jennifer L Patnaik; Christian Henning; Anne Lynch; Marcus A Glomb; Ram H Nagaraj
Journal:  Exp Eye Res       Date:  2021-07-21       Impact factor: 3.770

7.  Prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by Aegle marmelos.

Authors:  Rahman M Hafizur; Shahrukh Momin; Noor Fatima
Journal:  BMC Complement Altern Med       Date:  2017-04-21       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.